MHRA Developing Contingency Plan to New European API Import Rules

Faced with the possibility of drug shortages, UK regulators are developing backup plans to new EU importation rules for active pharmaceutical ingredient (API) manufacturers. The EU’s falsified medicines directive took effect July 2 with new requirements for importing APIs into Europe.
International Pharmaceutical Regulatory Monitor